| # | Drug | Count |
|---|---|---|
| 0 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 91 |
| 1 | EMTRICITABINE | 20 |
| 2 | NEVIRAPINE | 10 |
| 3 | ATAZANAVIR | 9 |
| 4 | RALTEGRAVIR | 9 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE | 9 |
| 6 | LAMIVUDINE | 8 |
| 7 | LAMIVUDINE ORAL | 8 |
| 8 | RITONAVIR | 8 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 91 | 0.0020 |
| 1 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 2 | RALTEGRAVIR | 9 | 0.0017 |
| 3 | ANTIHEMOPHILIC FACTOR HUMAN | 2 | 0.0015 |
| 4 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 5 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 6 | NEVIRAPINE | 10 | 0.0011 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 | 0.0009 |
| 8 | FACTOR IX COMPLEX | 1 | 0.0009 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 127 | 0.0012 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0005 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 13 | 0.0002 |
| 6 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 7 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |